Oxygenta Pharmaceutical has informed about the certificate dated October 03, 2024, issued by Venture Capital and Corporate Investments, Registrar and Transfer Agent of the Company, confirming the compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Second quarter ended on September 30, 2024.
The above information is a part of company’s filings submitted to BSE.